His scientific interests lie mostly in COPD, Internal medicine, Physical therapy, Intensive care medicine and Disease. He is interested in Obstructive lung disease, which is a field of COPD. His Internal medicine research is multidisciplinary, incorporating perspectives in Cardiology, Endocrinology and Pathology.
Alvar Agusti interconnects BODE index, Global health, Prospective cohort study, Spirometry and Comorbidity in the investigation of issues within Physical therapy. His studies deal with areas such as Quality of life, Precision medicine, Pharmacotherapy and Biomarker as well as Intensive care medicine. His work carried out in the field of Disease brings together such families of science as Integrated care, Quality of life, Systemic inflammation and Depression.
Alvar Agusti mainly investigates COPD, Internal medicine, Pulmonary disease, Intensive care medicine and Physical therapy. His COPD study combines topics from a wide range of disciplines, such as Exacerbation, Immunology and Disease, Cohort, Pathology. His Immunology research integrates issues from Chronic bronchitis and Respiratory disease, Lung.
In the field of Internal medicine, his study on Spirometry overlaps with subjects such as In patient. Alvar Agusti interconnects Precision medicine, Severity of illness and Asthma in the investigation of issues within Intensive care medicine. His Physical therapy research is multidisciplinary, incorporating elements of Prospective cohort study and Obstructive lung disease.
His primary areas of study are COPD, Internal medicine, Intensive care medicine, Pulmonary disease and MEDLINE. Obstructive lung disease is the focus of his COPD research. His research in Internal medicine tackles topics such as Gastroenterology which are related to areas like Microbiome.
His study in Intensive care medicine is interdisciplinary in nature, drawing from both Global health, Precision medicine and Bronchiectasis. His MEDLINE study combines topics in areas such as Epidemiology, Health care and 2019-20 coronavirus outbreak. In his work, Prospective cohort study is strongly intertwined with Risk factor, which is a subfield of Cohort.
His primary areas of investigation include COPD, Internal medicine, Intensive care medicine, Pulmonary disease and Disease. His primary area of study in COPD is in the field of Obstructive lung disease. The Internal medicine study combines topics in areas such as Gastroenterology and Cardiology.
His Intensive care medicine research incorporates elements of Pharmacological treatment, Precision medicine and MEDLINE. Alvar Agusti focuses mostly in the field of Pulmonary disease, narrowing it down to topics relating to Disease progression and, in certain cases, Pathogenesis, Confounding and Vital capacity. His work investigates the relationship between Disease and topics such as Lung that intersect with problems in Respiratory health and Systemic inflammation.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo;Suzanne S. Hurd;Alvar G. Agustí;Paul W. Jones.
American Journal of Respiratory and Critical Care Medicine (2007)
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
B. R. Celli;W. MacNee;A. Agusti;Antonio R Anzueto.
European Respiratory Journal (2004)
Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study
Jose M. Marin;Santiago J Carrizo;Eugenio Fernandez Vicente;Alvar G N Agusti.
The Lancet (2005)
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary
Claus F. Vogelmeier;Gerard J. Criner;Fernando J. Martinez;Antonio Anzueto.
American Journal of Respiratory and Critical Care Medicine (2017)
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
John R. Hurst;Jørgen Vestbo;Jørgen Vestbo;Antonio Anzueto;Nicholas Locantore.
The New England Journal of Medicine (2010)
Systemic effects of chronic obstructive pulmonary disease
A G N Agustí;A Noguera;J Sauleda;E Sala.
European Respiratory Journal (2003)
Characterisation of COPD heterogeneity in the ECLIPSE cohort
Àlvar Agustí;Peter Ma Calverley;Bartolome R Celli;Harvey O Coxson.
Respiratory Research (2010)
Chronic obstructive pulmonary disease phenotypes: the future of COPD.
Mei Lan K. Han;Alvar Agusti;Peter M. Calverley;Bartolome R. Celli.
American Journal of Respiratory and Critical Care Medicine (2010)
Mortality in COPD: role of comorbidities
D. D. Sin;N. R. Anthonisen;J. B. Soriano;A. G. Agusti.
European Respiratory Journal (2006)
Immunologic Aspects of Chronic Obstructive Pulmonary Disease
Manuel G. Cosio;Marina Saetta;Alvar Agusti.
The New England Journal of Medicine (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of Manchester
Brigham and Women's Hospital
Maastricht University
University of Edinburgh
Brigham and Women's Hospital
University College London
University of Barcelona
University of Liverpool
University of Bergen
University of Nebraska Medical Center
Columbia University
Paris School of Economics
Uppsala University
University of Tokyo
Tongji University
Georgia Institute of Technology
University of York
Broad Institute
University of Bordeaux
Shandong University
Copenhagen University Hospital
University of Maryland, College Park
Cleveland Clinic
Mayo Clinic
University of Nottingham
University of Groningen